|Datasheet||Specific References||Reviews||Related Products||Protocols|
|Vector Type||Mammalian Expression Vector|
|Expression Method||Constiutive, Stable / Transient|
|Selection In Mammalian Cells||Hygromycin|
A myc tag can be used in many different assays that require recognition by an antibody. If there is no antibody against the studied protein, adding a myc-tag allows one to follow the protein with an antibody against the Myc epitope. Examples are cellular localization studies by immunofluorescence or detection by Western blotting.
The peptide sequence of the myc-tag is: N-EQKLISEEDL-C (1202 Da). It can be fused to the C-terminus and the N-terminus of a protein. It is advisable not to fuse the tag directly behind the signal peptide of a secretory protein, since it can interfere with translocation into the secretory pathway.
|Human FAP ORF mammalian expression plasmid, C-GFPSpark tag||HG10464-ACG|
|Human FAP ORF mammalian expression plasmid, C-OFPSpark / RFP tag||HG10464-ACR|
|Human FAP ORF mammalian expression plasmid, C-Flag tag||HG10464-CF|
|Human FAP ORF mammalian expression plasmid, C-His tag||HG10464-CH|
|Human FAP ORF mammalian expression plasmid, C-Myc tag||HG10464-CM|
|Human FAP ORF mammalian expression plasmid, C-HA tag||HG10464-CY|
|Human FAP Gene cDNA clone plasmid||HG10464-M|
|Human FAP ORF mammalian expression plasmid, His tag||HG10464-M-H|
|Human FAP ORF mammalian expression plasmid, N-Flag tag||HG10464-NF|
|Human FAP ORF mammalian expression plasmid, N-His tag||HG10464-NH|
|Human FAP ORF mammalian expression plasmid, N-Myc tag||HG10464-NM|
|Human FAP ORF mammalian expression plasmid, N-HA tag||HG10464-NY|
|Human FAP natural ORF mammalian expression plasmid||HG10464-UT|
|Learn more about expression Vectors|
Seprase, also known as 170 kDa melanoma membrane-bound gelatinase , Fibroblast activation protein alpha, Integral membrane serine protease and FAP, is a single-pass type II membrane protein which belongs to the peptidase S9B family. Seprase / FAP is found in cell surface lamellipodia, invadopodia and on shed vesicles. Seprase / FAP appears to act as a proteolytically active 170-kDa dimer, consisting of two 97-kDa subunits. It is a member of the group type II integral serine proteases, which includes dipeptidyl peptidase IV ( DPPIV / CD26 ) and related type II transmembrane prolyl serine peptidases, which exert their mechanisms of action on the cell surface. Seprase / FAP colocalized with DPP4 in invadopodia and lamellipodia of migratory activated endothelial cells in collagenous matrix. Seprase / FAP colocalized with DPP4 on endothelial cells of capillary-like microvessels but not large vessels within invasive breast ductal carcinoma. DPP4 and seprase exhibit multiple functions due to their abilities to form complexes with each other and to interact with other membrane-associated molecules. In association with DPP4, Seprase / FAP is involved in the pericellular proteolysis of the extracellular matrix (ECM), the migration and invasion of endothelial cells into the ECM. Seprase / FAP has a dual function in tumour progression. The proteolytic activity of Seprase has been shown to promote cell invasiveness towards the ECM and also to support tumour growth and proliferation. Seprase / FAP may have a role in tissue remodeling during development and wound healing, and may contribute to invasiveness in malignant cancers.